1-1 of 1
Carlos A. Murga-Zamalloa, MD
Close
Sort by
Journal Articles

Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders

John C. Reneau, MD, Steven R. Hwang, MD, Carlos A. Murga-Zamalloa, MD, Joseph J. Buggy, PhD, James W. Janc, PhD, Ryan A. Wilcox, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4172.
https://doi.org/10.1182/blood-2018-99-110554
Published: 2018